Cart
sales@molnova.com
BI-69A11
CAS No. 1233322-09-2
BI-69A11 ( BI-69A11; BI 69A11; BI69A11 )
Catalog No. M10923 CAS No. 1233322-09-2
A potent, selective, ATP competitive AKT inhibitor with IC50 of 2.3 uM for Akt1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 47 | Get Quote |
|
| 5MG | 68 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 170 | Get Quote |
|
| 50MG | 245 | Get Quote |
|
| 100MG | 350 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBI-69A11
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, ATP competitive AKT inhibitor with IC50 of 2.3 uM for Akt1.
-
DescriptionA potent, selective, ATP competitive AKT inhibitor with IC50 of 2.3 uM for Akt1; displays no activity for other protein kinases including Abl1, p38α, JNK, and PI3K (IC50>100 uM); causes partial inhibition of AKT phosphorylation on S473 on melanoma cells at 3 uM; reduces AKT protein expression and AKT association with HSP-90; caused effective regression of melanoma tumor xenografts.
-
SynonymsBI-69A11; BI 69A11; BI69A11
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorAkt
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1233322-09-2
-
Formula Weight425.87
-
Molecular FormulaC25H16ClN3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC2=C(C=C(Cl)C=C2)C(C3=CC=CC=C3)=C1C(/C=C/C4=NC5=CC=CC=C5N4)=O
-
Chemical Name(E)-3-(3-(1H-benzo[d]imidazol-2-yl)acryloyl)-6-chloro-4-phenylquinolin-2(1H)-one(E)-3-(3-(1H-benzo[d]imidazol-2-yl)acryloyl)-6-chloro-4-phenylquinolin-2(1H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gaitonde S, et al. Pigment Cell Melanoma Res. 2009 Apr;22(2):187-95.
2. Feng Y, et al. Pigment Cell Melanoma Res. 2013 Jan;26(1):136-42.
3. Pal I, et al. Br J Cancer. 2014 Jul 8;111(1):101-11.
2. Feng Y, et al. Pigment Cell Melanoma Res. 2013 Jan;26(1):136-42.
3. Pal I, et al. Br J Cancer. 2014 Jul 8;111(1):101-11.
molnova catalog
related products
-
Akt1Akt2-IN-17
A potent, selective dual Akt1 and Akt2 inhibitor with IC50 of 3.5 nM and 42 nM, respectively.
-
Crosstide
Crosstide is a peptide analog of glycogen synthase kinase-3 (GSK-3) that functions as a natural substrate for Akt/PKB.
-
GSK-690693
A potent, ATP competitive, pan-AKT inhibitor with IC50 of 2, 13, and 9 nM against AKT1, 2, and 3, respectively.
